SANUWAVE Health, Inc. (SNWV)
USD 30.81
(2.09%)
USD 30.81
(2.09%)
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2023 | 65.59 Million USD | 7.74% |
| 2022 | 60.88 Million USD | 5.74% |
| 2021 | 57.57 Million USD | 56.69% |
| 2020 | 36.74 Million USD | 173.3% |
| 2019 | 13.44 Million USD | -18.68% |
| 2018 | 16.53 Million USD | 48.16% |
| 2017 | 11.15 Million USD | 40.97% |
| 2016 | 7.91 Million USD | 15.8% |
| 2015 | 6.83 Million USD | 9.95% |
| 2014 | 6.21 Million USD | -19.42% |
| 2013 | 7.71 Million USD | -7.81% |
| 2012 | 8.36 Million USD | 8.66% |
| 2011 | 7.7 Million USD | -43.13% |
| 2010 | 13.54 Million USD | 15.27% |
| 2009 | 11.75 Million USD | 15322.39% |
| 2008 | 76.19 Thousand USD | 47.75% |
| 2007 | 51.57 Thousand USD | 25.93% |
| 2006 | 40.95 Thousand USD | 0.0% |
| Year | Total Liabilities | Total Liabilities Growth |
|---|---|---|
| 2024 Q1 | 70.91 Million USD | 8.12% |
| 2024 Q2 | 60.61 Million USD | -14.52% |
| 2023 FY | 65.59 Million USD | 7.74% |
| 2023 Q1 | 71.28 Million USD | 17.09% |
| 2023 Q2 | 80.03 Million USD | 12.27% |
| 2023 Q4 | 65.59 Million USD | -23.99% |
| 2023 Q3 | 86.29 Million USD | 7.82% |
| 2022 Q3 | 52.96 Million USD | 1.03% |
| 2022 Q4 | 60.88 Million USD | 14.96% |
| 2022 FY | 60.88 Million USD | 5.74% |
| 2022 Q1 | 54.4 Million USD | -5.51% |
| 2022 Q2 | 52.42 Million USD | -3.64% |
| 2021 Q4 | 57.57 Million USD | 18.26% |
| 2021 FY | 57.57 Million USD | 56.69% |
| 2021 Q1 | 36.91 Million USD | 0.45% |
| 2021 Q2 | 44.99 Million USD | 21.89% |
| 2021 Q3 | 48.68 Million USD | 8.21% |
| 2020 Q4 | 36.74 Million USD | 8.91% |
| 2020 Q2 | 18.22 Million USD | 16.27% |
| 2020 Q3 | 33.73 Million USD | 85.08% |
| 2020 FY | 36.74 Million USD | 173.3% |
| 2020 Q1 | 15.67 Million USD | 16.61% |
| 2019 Q2 | 17.86 Million USD | 5.03% |
| 2019 Q4 | 13.44 Million USD | -10.14% |
| 2019 FY | 13.44 Million USD | -18.68% |
| 2019 Q1 | 17.01 Million USD | 2.9% |
| 2019 Q3 | 14.96 Million USD | -16.26% |
| 2018 Q1 | 14.84 Million USD | 33.0% |
| 2018 Q4 | 16.53 Million USD | 16.51% |
| 2018 Q3 | 14.19 Million USD | -10.49% |
| 2018 FY | 16.53 Million USD | 48.16% |
| 2018 Q2 | 15.85 Million USD | 6.81% |
| 2017 FY | 11.15 Million USD | 40.97% |
| 2017 Q4 | 11.15 Million USD | 16.38% |
| 2017 Q3 | 9.58 Million USD | 8.72% |
| 2017 Q2 | 8.81 Million USD | 7.29% |
| 2017 Q1 | 8.22 Million USD | 3.84% |
| 2016 Q1 | 6.65 Million USD | -2.66% |
| 2016 FY | 7.91 Million USD | 15.8% |
| 2016 Q4 | 7.91 Million USD | 17.3% |
| 2016 Q3 | 6.74 Million USD | -1.35% |
| 2016 Q2 | 6.84 Million USD | 2.81% |
| 2015 Q4 | 6.83 Million USD | 3.16% |
| 2015 Q1 | 6.18 Million USD | -0.5% |
| 2015 Q2 | 6.75 Million USD | 9.12% |
| 2015 FY | 6.83 Million USD | 9.95% |
| 2015 Q3 | 6.62 Million USD | -1.83% |
| 2014 Q4 | 6.21 Million USD | -1.84% |
| 2014 FY | 6.21 Million USD | -19.42% |
| 2014 Q2 | 6.32 Million USD | -7.65% |
| 2014 Q1 | 6.85 Million USD | -11.2% |
| 2014 Q3 | 6.33 Million USD | 0.1% |
| 2013 Q2 | 13.36 Million USD | -2.06% |
| 2013 FY | 7.71 Million USD | -7.81% |
| 2013 Q3 | 7.8 Million USD | -41.62% |
| 2013 Q4 | 7.71 Million USD | -1.12% |
| 2013 Q1 | 13.64 Million USD | 63.07% |
| 2012 Q1 | 7.69 Million USD | -0.16% |
| 2012 FY | 8.36 Million USD | 8.66% |
| 2012 Q4 | 8.36 Million USD | 7.26% |
| 2012 Q3 | 7.8 Million USD | 1.33% |
| 2012 Q2 | 7.7 Million USD | 0.14% |
| 2011 Q2 | 8.17 Million USD | -40.14% |
| 2011 FY | 7.7 Million USD | -43.13% |
| 2011 Q1 | 13.65 Million USD | 0.77% |
| 2011 Q4 | 7.7 Million USD | -2.81% |
| 2011 Q3 | 7.92 Million USD | -3.01% |
| 2010 Q4 | 13.54 Million USD | -16.16% |
| 2010 Q1 | 13.34 Million USD | 13.58% |
| 2010 FY | 13.54 Million USD | 15.27% |
| 2010 Q2 | 14.5 Million USD | 8.68% |
| 2010 Q3 | 16.15 Million USD | 11.38% |
| 2009 FY | 11.75 Million USD | 15322.39% |
| 2009 Q4 | 11.75 Million USD | 2.98% |
| 2009 Q3 | 11.41 Million USD | 17896.52% |
| 2009 Q2 | 63.41 Thousand USD | 5.04% |
| 2009 Q1 | 60.36 Thousand USD | -20.78% |
| 2008 Q1 | 50.57 Thousand USD | -1.92% |
| 2008 FY | 76.19 Thousand USD | 47.75% |
| 2008 Q2 | 70.14 Thousand USD | 38.69% |
| 2008 Q3 | 74.71 Thousand USD | 6.51% |
| 2008 Q4 | 76.19 Thousand USD | 1.99% |
| 2007 FY | 51.57 Thousand USD | 25.93% |
| 2007 Q4 | 51.57 Thousand USD | 0.0% |
| 2006 FY | 40.95 Thousand USD | 0.0% |
| Name | Total Liabilities | Total Liabilities Difference |
|---|---|---|
| Avitar, Inc. | 11.59 Million USD | -465.781% |
| BioElectronics Corporation | 16.62 Million USD | -294.602% |
| CVR Medical Corp. | - USD | -Infinity% |
| IR-Med Inc. | 634 Thousand USD | -10246.057% |
| Medical Supply International USA, Inc. | 677.61 Thousand USD | -9580.114% |
| Polarean Imaging plc | 2.58 Million USD | -2441.872% |
| AVITA Medical, Inc. | 19.86 Million USD | -230.192% |
| Manhattan Scientifics, Inc. | 2.11 Million USD | -2996.978% |
| Össur hf. | 688.8 Million USD | 90.477% |
| Zecotek Photonics Inc. | 5.86 Million USD | -1017.71% |
| QHSLab, Inc. | 2.05 Million USD | -3088.743% |
| Wellstar International, Inc. | 55.99 Million USD | -17.152% |
| Össur hf. | 688.8 Million USD | 90.477% |
| Bionovate Technologies Corp | - USD | -Infinity% |
| EKF Diagnostics Holdings plc | 16.08 Million USD | -307.909% |
| Escalon Medical Corp. | 2.94 Million USD | -2124.775% |
| Aurora Spine Corporation | 6.65 Million USD | -885.852% |
| BrainsWay Ltd. | 15.31 Million USD | -328.327% |
| Lattice Biologics Ltd. | - USD | -Infinity% |
| NewCardio, Inc. | 6.01 Million USD | -990.934% |
| Hamilton Thorne Ltd. | 45.84 Million USD | -43.085% |
| Vivos Inc. | 245 Thousand USD | -26672.624% |
| MicroPort Scientific Corporation | 2.48 Billion USD | 97.362% |
| Kelyniam Global, Inc. | 1.01 Million USD | -6375.638% |
| REMSleep Holdings, Inc. | 275.61 Thousand USD | -23699.226% |
| CYduct Diagnostics, Inc. | 2.44 Million USD | -2577.516% |
| Nanomix Corporation | 14.81 Million USD | -342.762% |
| Theraclion SA | 13.01 Million EUR | -403.927% |
| Lifeline Biotechnologies, Inc. | - USD | -Infinity% |
| Wellness Center USA, Inc. | 5.12 Million USD | -1180.083% |
| Positron Corporation | 2.02 Million USD | -3137.614% |
| Rafina Innovations Inc. | - USD | -Infinity% |
| Electromedical Technologies, Inc. | 3.62 Million USD | -1711.403% |
| Lombard Medical, Inc. | 53.79 Million USD | -21.936% |
| ALR Technologies Inc. | 24.5 Million USD | -167.672% |
| Stratec SE | 271.97 Million USD | 75.882% |
| Vycor Medical, Inc. | 4.31 Million USD | -1419.162% |
| Heart Tronics, Inc. | 1.09 Million USD | -5891.474% |
| Nu-Med Plus, Inc. | 2.35 Million USD | -2680.837% |
| Perimeter Medical Imaging AI, Inc. | 5.47 Million USD | -1097.721% |
| VMS Rehab Systems, Inc. | 201.36 USD | -32575386.194% |
| Guided Therapeutics, Inc. | 5.47 Million USD | -1098.064% |
| Ingen Technologies, Inc. | 5.7 Million USD | -1048.848% |
| Odyssey Group International, Inc. | 6.61 Million USD | -892.086% |
| United American Healthcare Corporation | 119 Thousand USD | -55021.008% |
| ECGI Holdings, Inc. | 11.94 Million USD | -449.347% |
| Capital Group Holdings, Inc. | 1.32 Million USD | -4854.289% |
| ADM Tronics Unlimited, Inc. | 1.44 Million USD | -4435.181% |
| Urologix, Inc. | 12.64 Million USD | -418.776% |
| Rapid Therapeutic Science Laboratories, Inc. | 5.39 Million USD | -1115.59% |
| Nexeon MedSystems Inc. | 8.48 Million USD | -673.29% |
| SS Innovations International, Inc. | 11.18 Million USD | -486.651% |
| Qualis Innovations, Inc. | 525.38 Thousand USD | -12384.892% |
| Smith & Nephew plc | 4.76 Billion USD | 98.623% |
| NIOX Group Plc | 9.8 Million USD | -569.183% |
| Fuse Medical, Inc. | 15.11 Million USD | -334.108% |
| Broncus Holding Corporation | 10.43 Million USD | -528.767% |
| Brain Scientific Inc. | 7.42 Million USD | -783.254% |
| Pressure BioSciences, Inc. | 33.8 Million USD | -94.045% |
| Health Logic Interactive Inc. | 794.08 Thousand USD | -8160.366% |